Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N -arylpiperazine Derivatives Characterized as D 2 /D 3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases.

MLA

da Silva Cunha, Thayssa Tavares, et al. “Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N -Arylpiperazine Derivatives Characterized as D 2 /D 3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases.” Biomolecules, vol. 12, no. 8, Aug. 2022. EBSCOhost, https://doi.org/10.3390/biom12081112.

APA

da Silva Cunha, T. T., Silva, R. R., Rodrigues, D. A., de Sena Murteira Pinheiro, P., Kronenberger, T., Sant’Anna, C. M. R., Noël, F., & Fraga, C. A. M. (2022). Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N -arylpiperazine Derivatives Characterized as D 2 /D 3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases. Biomolecules, 12(8). https://doi.org/10.3390/biom12081112

Chicago

da Silva Cunha, Thayssa Tavares, Rafaela Ribeiro Silva, Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Thales Kronenberger, Carlos Maurício R Sant’Anna, François Noël, and Carlos Alberto Manssour Fraga. 2022. “Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N -Arylpiperazine Derivatives Characterized as D 2 /D 3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases.” Biomolecules 12 (8). doi:10.3390/biom12081112.